We are the first drug to show a statistically sign
Post# of 148175
Leronlimab meets every requirement for EUA. Whether the FDA awards is to be seen.
With respect to the phase 3 trial, it doesnt need to be large and if we are awarded an EUA, it will enroll very quickly.
Even without EUA, it will likely enroll faster than the phase 2 given the positive results.